Shanghai Pharmaceuticals Holding Co., Ltd is a leading company in the development of the biopharmaceutical industry in Shanghai. It was formed through the merger of Shanghai Pharmaceuticals, Chinese-Western Pharmaceuticals, and a third company. The company is primarily engaged in pharmaceutical research and development, manufacturing, distribution, and retail. It owns several core manufacturing enterprises, including Xinyi, Guangdong Tempus, Biochemical, New Asia, Changyao, Medicinal Materials, Qingdao Guofeng, Huqingyutang, and Zhengda Qingchunbao. Its production covers a wide range of products in the fields of chemical preparations, biological preparations, traditional Chinese medicine and health products, and chemical raw materials. The company has a strong distribution network, ranking among the top in East China, Shanghai, and nationwide, with distribution channels covering several provinces and cities in China. According to the Chairman of Shanghai Pharmaceuticals, Lv Mingfang, the company is expected to inject antibiotic business assets into the listed company in the second half of the year.
Headquarters
Shanghai Medical Building, No. 200 Taicang Road, Shanghai
Shanghai; Shanghai;
Postal Code: 200020
Contact Details: Purchase the Shanghai Pharmaceuticals Holding Co.,Ltd report to view the information.
Website: http://www.sphchina.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service